Design Therapeutics (DSGN) Property, Plant & Equipment (Net) (2020 - 2026)

Design Therapeutics (DSGN) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - 642,333.36
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 518.26 Mn
10 Design Therapeutics 738.44 Mn 515.62 Mn - 824,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 824,000.00
Mar 31, 2026 824,000.00
Dec 31, 2025 981,000.00
Dec 31, 2025 981,000.00
Sep 30, 2025 1.10 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.26 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.38 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 1.41 Mn
Dec 31, 2024 1.41 Mn
Sep 30, 2024 1.56 Mn
Sep 30, 2024 1.56 Mn
Jun 30, 2024 1.73 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 1.72 Mn
Mar 31, 2024 1.72 Mn
Dec 31, 2023 1.69 Mn
Dec 31, 2023 1.69 Mn